Final Programme - iuphar

W02 Symposium on advances in GI pharmacology
Organized by: IUPHAR Gastrointestinal Pharmacology Section
Leader: Sando Szabo, (USA)
Part II – Advances in GI pharmacology: From functional to structural
disease targets
Chairs: Sandor Szabo, (USA) & Koji Takeuchi, (Japan)
09:30 - 09:35 W02.2.1 GI pharmacology: the importance of bench-to-bedside-and-back concept
Duan Chen, (Norway)
09:35 - 10:00 W02.2.2 The changing organ/disease targets & new molecular mechanisms in GI pharmacology
Sandor Szabo, (USA)
10:00 - 10:25 W02.2.3 The evolution of proton pump inhibitors: lansoprazole protects the gastrointestinal
mucosa by a mechanism unrelated to antisecretory action
Hiroshi Satoh, (Japan), K Amagase, K Takeuchi
10:25 - 10:50 COFFEE BREAK
10:50 - 11:15 W02.2.4 Prostaglandin EP receptors and their roles in mucosal protection and ulcer healing in
gastrointestinal tract
Koji Takeuchi, (Japan)
11:15 - 11:40 W02.2.5 Glucocorticoids ARE gastroprotective – in physiologic conditions
Ludmila Filaretova, (Russian Federation)
11:40 - 11:55 W02.2.6 CYP2C9*3 is a potent risk factor for NSAID induced gastrointestinal bleeding
Laurent Becquemont, (France), N Carbonell, C Verstuyft, J Massard, A Letierce,
C Cellier, L Deforges, F Saliba, JC Delchier
11:55 - 12:10 W02.2.7 New pharmacologic approach to ulcerative colitis (UC): novel use of D2 dopamine
receptor (D2R) agonists
Ganna Tolstanova, (Ukraine), X Deng, T Kaplan, B Paunovic, S Szabo, Z Sandor
12:15 - 12:45 LUNCH BREAK
40 Monday 19 July ■ 09:30 - 12:15 ■ Meeting Room BV 1/2/3